NCT04976907

Brief Summary

The impact of the coronavirus disease (COVID)-19 pandemic on global healthcare systems has prompted a search for novel tools to stem the tide. New digital health tools can provide possible health solutions in this time of unprecedented medical crisis to mitigate the impact of this pandemic. This proof of concept study will determine the feasibility and effectiveness of implementing a mobile application for contactless screening and vital signs measurement (MAC-VITAL) such as blood pressure (BP), heart rate (HR), respiratory rate (RR), oxyhemoglobin saturation (SpO2), temperature from surgical patients peri-operatively. Contactless measurement of vital signs will bridge the current gap between virtual care and in-person medical assessments.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2021

Shorter than P25 for all trials

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 15, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 26, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

September 14, 2021

Status Verified

September 1, 2021

Enrollment Period

1 year

First QC Date

July 15, 2021

Last Update Submit

September 8, 2021

Conditions

Outcome Measures

Primary Outcomes (7)

  • Systolic blood pressure difference from reference measurement (mmHg)

    Assessed against standard clinical grade instrument: automated oscillometric blood pressure device (mmHg)

    Perioperative

  • Diastolic blood pressure difference from reference measurement (mmHg)

    Assessed against standard clinical grade instrument: automated oscillometric blood pressure device (mmHg)

    Perioperative

  • Blood oxygenation (SpO2) difference from reference measurement (% oxyhemoglobin saturation)

    Assessed against standard clinical grade instrument: Finger-based pulse oximeter (% oxyhemoglobin saturation)

    Perioperative

  • Pulse rate difference from reference measurement (beats per minute)

    Assessed against standard clinical grade instrument: Finger-based pulse oximeter (beats per minute)

    Perioperative

  • Teperature difference from reference measurement (degrees Celsius)

    Assessed against standard clinical grade instrument: Forehead digital thermometer (degrees Celsius)

    Perioperative

  • Respiratory rate difference from reference measurement (breaths per minute)

    Assessed against standard clinical grade instrument: Visual count of chest rise and fall (breaths per minute)

    Perioperative

  • Obstacles to using the mobile application

    Characterization of obstacles to the implementation of the mobile app for perioperative vital sign measurements.

    Perioperative

Secondary Outcomes (5)

  • Detection rate of clinically meaningful changes of vital signs

    Perioperative

  • Ease of use survey

    Perioperative

  • Satisfaction survey

    Perioperative

  • Study participation

    Perioperative

  • Compliance with measurement protocol

    Perioperative

Study Arms (1)

Perioperative patients

Patients undergoing perioperative assessment of vital signs.

Device: Contactless vital sign information collection

Interventions

Collection of facial blood flow and temperature information via conventional and infrared/thermal video of the face for the purpose of estimating vital signs using machine learning-based computational models.

Perioperative patients

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients scheduled to undergo elective surgery under general and/or regional anesthesia.

You may qualify if:

  • Patients scheduled to undergo elective surgery under general and/or regional anesthesia
  • + years of age

You may not qualify if:

  • Refusal to consent for the study
  • Non-English speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Hamilton General Hospital (Hamilton Health Sciences)

Hamilton, Ontario, L8L 2X2, Canada

Location

Juravinski Hospital (Hamilton Health Sciences)

Hamilton, Ontario, L8V 1C3, Canada

Location

Toronto General Hospital

Toronto, Ontario, M5G 2C4, Canada

Location

Toronto Western Hospital, University Health Network

Toronto, Ontario, M5T 2S8, Canada

Location

Study Officials

  • Frances Chung, MBBS, FRCPC

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Frances Chung, MBBS, FRCPC

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 15, 2021

First Posted

July 26, 2021

Study Start

October 1, 2021

Primary Completion

October 1, 2022

Study Completion

October 1, 2022

Last Updated

September 14, 2021

Record last verified: 2021-09

Locations